Cure Sanfilippo Foundation Report issue

Foundation Phase 3

Organization Overview

First Clinical Trial
2019
NCT04018755
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Cure Sanfilippo Foundation